Skip to content

MDMA: all studies

Page 179 of 345: studies 1,781 to 1,790 of 3,446, newest first. Back to the MDMA overview

Research

Ecstasy (MDMA): a review of its possible persistent psychological effects

Psychopharmacology September 7, 2000 M. Morgan

Abstract. Rationale: Recreational use of "ecstasy" (3,4-methylenedioxymethamphetamine; MDMA) has become increasingly widespread. Until recently, however, little was known about the possible persistent psychological effects of extensive use of this drug. Objective: The aim of the present review is to evaluate recent empirical evidence concerning the persistent psychological sequelae of...

2‐Deoxy‐D‐Glucose Prevents and Nicotinamide Potentiates 3,4‐Methylenedioxymethamphetamine‐Induced Serotonin Neurotoxicity

Journal of Neurochemistry September 1, 2000 Isabel Hervias, Berta Lasheras, Norberto Aguirre

Abstract: Neurotoxicity induced by different substituted amphetamines has been associated with the exhaustion of intracellular energy stores. Accordingly, we examined the influence of 2‐deoxy‐D‐glucose (2‐DG), a competitive inhibitor of glucose uptake and metabolism, and nicotinamide, an agent that improves energy metabolism, on 3,4‐methylenedioxymethamphetamine (MDMA)‐induced...

Aortic Dissection After Ingestion of "Ecstasy" (MDMA)

American Journal of Forensic Medicine & Pathology September 1, 2000 Johan Duflou, Adam M. Mark 51 citations

The authors report a case of aortic dissection and cardiac tamponade in a 29-year-old man after ingestion of ecstasy (methylenedioxymethamphetamine, MDMA) at a "rave" party. There was no history of hypertension, myxoid heart disease, or other risk factors for aortic dissection in the deceased, although a minor degree of cystic medial necrosis was noted on histologic examination of the aorta....

Immunomodulating Activity of MDMA

Annals of the New York Academy of Sciences September 1, 2000 Roberta Pacifici, Piergiorgio Zuccaro, Magı́ Farré et al. 44 citations

Abstract MDMA (3,4‐methylenedioxymethamphetamine) use can cause neurochemical, behavioral and endocrine alterations, similar to those produced by exposure to acute stress, suggesting its potential as a “chemical stressor.” It is known that stressful stimuli can produce a depression of immune function and an alteration in immune cells distribution. In vitro exposure to MDMA resulted in a...

DOI: 10.1111/j.1749-6632.2000.tb05198.x (opens in new tab) MDMA Immune system Endocrinology Neurochemical +5

Pharmacology of MDMA in Humans

Annals of the New York Academy of Sciences September 1, 2000 Rafael de la Torre, Magı́ Farré, Pere N. Roset et al. 178 citations

Abstract MDMA given at recreational doses (range tested 50 to 150 mg) to healthy volunteers, produced mydriasis and marked increases in systolic and diastolic blood pressure, heart rate, and pupillary diameter. MDMA induced changes on oral temperature. The time course of this observation was biphasic, as a slight decrease at 1 h and a slight increase at 2 and 4 h were observed. MDMA induced a...

Agony and ecstasy: a review of MDMA effects and toxicity

European Psychiatry August 1, 2000 C. Burgess, Alan O'Donohoe, Michael Gill 108 citations

Summary Background Background – Ecstasy is a recreational drug with an anecdotal reputation for safety. However, reports of adverse effects and fatalities have increased in the medical and popular press. Methods Method – Literature search and review. Results Results – Acute Ecstasy toxicity does not appear to be due to overdose and cannot be solely attributed to the nature of the usual ambient...

Human Pharmacology of 3,4-Methylenedioxymeth-amphetamine ("Ecstasy"): Psychomotor Performance and Subjective Effects

Journal of Clinical Psychopharmacology August 1, 2000 Jordi Camı́, Magı́ Farré, Marta Más et al. 237 citations

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") is a recreational drug of increasing use among youth because of its apparent entactogenic properties, such as euphoria, friendliness, closeness, and empathy. However, experimental studies have shown MDMA to be neurotoxic. Data on pharmacologic actions of MDMA in humans are limited. The authors conducted a randomized, double-blind, crossover,...

Striatal serotonin is depleted in brain of a human MDMA (Ecstasy) user

Neurology July 25, 2000 Stephen J. Kish, Yoshiaki Furukawa, Lee-Cyn Ang et al. 119 citations

The authors found that striatal levels of serotonin and those of its metabolite 5-hydroxyindoleacetic acid were severely depleted by 50 to 80% in brain of a chronic user of methylenedioxymethamphetamine (MDMA) whereas concentrations of dopamine were within the normal control range. Our data suggest that MDMA exposure in the human can cause decreased tissue stores of serotonin and therefore some...

MDMA (“Ecstasy”) Abuse and High-Risk Sexual Behaviors Among 169 Gay and Bisexual Men

American Journal of Psychiatry July 1, 2000 Robert Klitzman, Harrison G. Pope, James I. Hudson 132 citations

OBJECTIVE: The authors explored the association between abuse of 3,4-methylenedioxymethamphetamine (MDMA, or “Ecstasy”) and high-risk sexual behaviors among gay and bisexual men. METHOD: An anonymous questionnaire was completed by 169 gay and bisexual men at three New York City dance clubs. The questionnaire covered demographic indices, use of MDMA and other drugs, and history of high-risk...

DOI: 10.1176/appi.ajp.157.7.1162 (opens in new tab) Ecstasy MDMA Ethnic group Association psychology +7

Identification of the human cytochromes P450 involved in the oxidative metabolism of "Ecstasy"-related designer drugs.

Biochemical Pharmacology June 15, 2000 K Kreth, K Kovar, M Schwab et al.

The human cytochrome P450 (CYP) isozymes catalyzing the oxidative metabolism of the widely abused amphetamine derivatives MDMA (N-methyl-3,4-methylenedioxyamphetamine, "Ecstasy"), MDE (N-ethyl-3, 4-methylenedioxyamphetamine, "Eve"), and MDA (3, 4-methylenedioxyamphetamine) were identified. Using a simplified non-extractive reversed-phase HPLC assay with fluorescence detection, biphasic...